Physician profile
John Baker
NPI 1821389081
$2,757.61
in general payments reported to CMS, 2019-2025
20 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $13.91 · 2022: $1,927 · 2023: $42.76 · 2024: $209 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.26 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap Implant Systems, LLC | $1,623.24 | 2022 | |
| Intuitive Surgical, INC. | $322.83 | 2019-2022 | |
| Integra Lifesciences Corporation | $176.95 | 2022-2024 | Acell, Integra, Primatrix |
| Davol INC. | $169.86 | 2019-2022 | |
| Ethicon US, LLC | $80.91 | 2019-2025 | Stratafix, Dermabond Prineo, Vistaseal |
| Urgo Medical North America, LLC | $54.43 | 2024-2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Conmed Corporation | $48.43 | 2019-2023 | Airseal |
| Solventum Corporation | $47.82 | 2024-2025 | Activ.A.C. |
| Smith+Nephew, INC. | $32.82 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $27.60 | 2022 | |
| Kerecis Limited | $24.65 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $23.58 | 2025 | |
| Hartmann USA, INC. | $19.80 | 2025 | Zetuvit Plus 10x10 P10 |
| Mimedx Group, INC. | $19.66 | 2025 | |
| Cook Medical LLC | $18.19 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $15.04 | 2023 | Sutab |
| W. L. Gore & Associates, INC. | $13.91 | 2020 | |
| Csl Behring | $13.35 | 2023 | Kcentra |
| Bioventus LLC | $13.26 | 2019 | |
| Phathom Pharmaceuticals, INC. | $11.28 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.